For providers
Helping doctors prescribe biosimilars that can help
break through the cost barrier.
How can a doctor prescribe a breakthrough biologic if the cost barrier can’t be broken through? We’re leveraging
our heritage in generics to build a strong and growing portfolio of advanced biosimilar medicines to help improve
drug access and affordability.
2021 Teva Pharmaceuticals, Inc. NPS-40382 November 2021. This site is intended for US residents only.